UNSPSC 41131702: Antithrombin iii assay

In this classification an antithrombin III assay is a device that is used to determine the plasma level of antithrombin III (a substance which acts with the anticoagulant heparin to prevent coagulation). This determination is used to monitor the administration of heparin in the treatment of thrombosis US FDA regulates Antithrombin iii assay under 21 CFR 864.7060 and under FDA product code JPE.

UNSPSC 41131702 Antithrombin III assay is a Commodity code that in recent state and local procurement maps to a much broader set of drug testing, screening, and clinical laboratory services than the code name alone suggests. State and local governments are buying immunoassay and confirmatory drug testing (LC/MS/MS, GC/MS), urinalysis panels for substance abuse monitoring, forensic reference materials and drug standards for evidentiary analysis, breath alcohol testing equipment, employment screening and pre-placement drug testing, and medical director and occupational health services bundled with drug testing. The issuing bodies include county community supervision and corrections departments, county human resources divisions, county forensic laboratories, city college systems, state public safety agencies, and county sheriff and law enforcement operations. Collin County Community Supervision and Corrections Department, Seminole County, Benton County in Oregon, Pinellas County in Florida, Collier County in Florida, Clay County in Florida, City Colleges of Chicago, and the Nevada Department of Public Safety have all posted opportunities under or near this code within the past four months.

Recent activity spans Texas, Florida, Oregon, Illinois, and Nevada. Collin County's RFP 2026-327, posted July 9, 2026 with response due July 23, 2026, solicits offender drug testing services—specimen collection at two sites, immunoassay screening with confirmatory testing, electronic result reporting, and alternative testing methodologies including oral fluid and hair testing—with estimated annual volume of approximately 25,031 tests and contract value of $600,000 over two years with three optional one-year renewals. Benton County, Oregon's RFP, posted June 6, 2026 with response due July 7, 2026, requests urinalysis testing services (standard drug panels with confirmatory testing) for its Family Treatment Court Program with twice-weekly minimum testing, results within 48–72 hours, and a one-year initial term with optional annual renewals up to five years. Pinellas County, Florida's ITQ 26-0305, posted April 23, 2026 with response same day, procures 131 line items of certified drug reference standards and controls for forensic method validation and evidentiary analysis, funded through the Paul Coverdell Forensic Sciences Improvement Act Program with $49,034 designated for supplies. Nevada Department of Public Safety's bid solicitations (65DPSS3654 and 65DPSS3655), posted January 23 and January 26, 2026 with February deadlines, seek Intoxilyzer 9000 breath alcohol testing devices and printers. City Colleges of Chicago's RFP MWJ2603, posted February 18, 2026 with response due March 30, 2026, covers pre-employment drug testing, fitness-for-duty screening, and background investigation services for approximately 1,500–1,600 annual candidates with MBE (25%) and WBE (7%) participation goals.